Coldstream Capital Management Inc 89bio, Inc. Call Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ETNB
# of Institutions
193Shares Held
139MCall Options Held
212KPut Options Held
1.06M-
Janus Henderson Group PLC London, X020.5MShares$170 Million0.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$118 Million1.76% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.2MShares$84.7 Million3.26% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.32MShares$77.3 Million2.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$59.5 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $386M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...